Edesa Biotech
EDSA
Edesa Biotech (EDSA) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Nov 3, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $5.00 | Jun 27, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Mar 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Aug 20, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Jun 28, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 | Feb 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $21.00 from $70.00 | Nov 29, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Nov 22, 2023 |
| Brookline Capital | Maintained | Buy | $57.00 | Oct 12, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $16.00 | Aug 15, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $16.00 | May 24, 2023 |
Frequently asked questions
What is the latest analyst rating on EDSA?
On Nov 3, 2025, HC Wainwright & Co. maintained Edesa Biotech at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.